Retina

Avacincaptad pegol may help preserve driving-related vision in geographic atrophy, but post hoc data did not reach statistical significance.

Ischemic retinal disorders may signal underlying cardiovascular risk, making diagnostic imaging workup essential.

The device is described as “a wireless brain implant designed to provide artificial vision for people with total blindness by bypassing the eyes and optic nerves and connecting directly to the brain’s visual cortex.

Dimitra Skondra, MD, PhD, discussed her talk on how the diet and gut microbiome can affect the development of age-related macular degeneration.

ECG-synchronized Doppler holography provides repeatable measurements of the retinal blood flow.

The study, published in PLoS Genetics, examined how glucose metabolism affects gene expression in light-sensing photoreceptors.

Researchers noted growing evidence supporting an additional role for B vitamins.

What to know about the current state of artificial intelligence and multimodal retinal imaging in systemic disease surveillance in eye care.

At 12 weeks, improvements in visual and anatomical outcomes were observed across all groups.

The analysis included 12,183,254 patients, with 304,823 identified as smokers and 11,878,431 as non-smokers.

The decision lengthens the approved treatment period outlined in the prescribing information and may lessen the need to change therapies for patients who continue to show a lasting response.

Images showed that Parkinson disease is associated with a thicker photoreceptor nuclear layer and a thinner layer of photoreceptor processes.

Host Hamza Shah, OD, MS, FAAO, is joined by Raman Bhakhri, OD, FAAO, to discuss geographic atrophy, spurred by Del Priore's paper, "Is geographic atrophy a peripheral retinal disease?"

Sex hormones play important but distinct roles in regulating the ocular surface and adnexal tissues.

Phase 2 ArMaDa data show statistically significant 31% reduction in geographic atrophy lesion growth with OCU410 at 12 months, with a favorable safety profile supporting phase 3 development.

Luminopia, formerly cleared by the FDA for amblyopia in children, has begun its foray into IXT with positive data from a preliminary investigation.

Meta-analysis finds refraction change better than axial length thresholds for tracking childhood myopia, urging growth-curve AL monitoring to flag retinal risk.

Jeffry D. Gerson, OD, FAAO, shares how early exposure to retinal disease, mentorship, and hands-on OCT experience shaped his career and inspired a commitment to education and collaboration with ophthalmology.

The ADVISE trial has demonstrated adalimumab’s superior management of intermediate uveitis, posterior uveitis, or panuveitis requiring immunosuppression.

A recent study highlights the efficacy of the FAi implant in patients with NIU-related macular edema, improving BCVA and reducing choroidal thickness.

According to recent data, patients initiating semaglutide had a substantially greater risk of developing NAION versus those starting SGLT2 inhibitors.

This evidence-based eye care podcast seeks to turn research into practical clinical decisions, with new episodes on the first Monday of each month featuring expert guests across glaucoma, retina, dry eye, AI, and more.

In recent months, developments have ranged from regulatory setbacks to real-world data releases.

The prospective observational study is being conducted across 18 countries.